Agitation: Clinical Trials

14 trials for Agitation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 14

Follow Agitation: new trials by email Literature Review of Agitation trials Research Report on Agitation

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine
Mirtazapine, Melatonin, Placebo - Agitation
Phase 4CompletedAin Shams University1652021-06-152022-04-15
TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
Haloperidol + Promethazine + Chlorpromazine, Haloperidol + Promethazine - Psychiatric Emergency, Aggression
Phase 4CompletedJoseph Dib1002018-08-282022-06-14
Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting
Staccato® Delivery System Loxapine (ADASUVE®) - Agitation
Phase 4CompletedFerrer Internacional S.A.3232016-09-082020-11-04
Comparison of Ketamine-propofol Combinations
Ketamine-propofol mixture - Agitation, Postoperative Pain
Phase 4CompletedCukurova University752016-07-012017-04-20
Scalp Nerve Block on Emergence Agitation
Ropivacaine, Remifentanil, Sevoflurane - Agitation
Phase 4CompletedAjou University School of Medicine442015-05-012017-01-25
Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure
Propofol, Dexmedetomidine, Fentanyl - Sepsis, Respiratory Failure
Phase 4CompletedTexas Tech University Health Sciences Center362014-08-012020-03-02
Dexmedetomidine to Prevent Agitation After Free Flap Surgery
Dexmedetomidine, Saline placebo - Agitation, Delirium
Phase 4CompletedPeking University802013-06-012014-11-13
Treating Acutely Agitated Patients With Asenapine Sublingual Tablets
Asenapine, Placebo - Agitation
Phase 4CompletedUnity Health Toronto1202012-04-012016-05-16
Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery
saline, Dexmedetomidine - Agitation
Phase 4CompletedYonsei University742011-10-012015-02-06
Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone
Escitalopram, Risperidone - Agitation, Psychosis
Phase 4CompletedAbarbanel Mental Health Center402008-04-012015-06-24
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
Quetiapine, Haloperidol, Lorazepam - Agitation
Phase 4CompletedUniversity of Southern California722006-05-012019-07-26
Antipsychotic Discontinuation in Alzheimer's Disease
risperidone - Alzheimer Disease, Psychotic Disorders
Phase 4CompletedNew York State Psychiatric Institute1802004-08-012013-04-24
Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children
risperidone - Agitation
Phase 4CompletedStony Brook University242003-01-012008-11-13
Treatment of Behavioral Symptoms in Alzheimer's Disease
Haloperidol-Haloperidol, Haloperidol-Placebo - Alzheimer's Disease, Psychosis
Phase 4CompletedNew York State Psychiatric Institute441999-01-012016-05-24

Narrower conditions

Psychomotor Agitation (14)  ·  Psychotic Disorders (4)  ·  Alzheimer Disease (3)  ·  Aggression (2)  ·  Schizophrenia (2)  ·  Bipolar Disorder (1)  ·  Delirium (1)  ·  Dementia (1)  ·  Pain, Postoperative (1)  ·  Respiratory Insufficiency (1)  ·  Sepsis (1)

Broader conditions

Aberrant Motor Behavior in Dementia (14)  ·  Behavior (14)  ·  Behavioral Symptoms (14)  ·  Dyskinesias (14)  ·  Nervous System Diseases (14)  ·  Neurobehavioral Manifestations (14)  ·  Neurologic Manifestations (14)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Psychomotor Disorders (14)  ·  Signs and Symptoms (14)  ·  Mental Disorders (6)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (5)  ·  Neurocognitive Disorders (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)

Interventions

Dexmedetomidine (3)  ·  Haloperidol (3)  ·  Risperidone (3)  ·  Benztropine (1)  ·  Chlorpromazine (1)  ·  Dexetimide (1)  ·  Escitalopram (1)  ·  Fentanyl (1)  ·  Lorazepam (1)  ·  Melatonin (1)  ·  Mirtazapine (1)  ·  Promethazine (1)  ·  Propofol (1)  ·  Quetiapine Fumarate (1)  ·  Remifentanil (1)

Sponsors

New York State Psychiatric Institute (2)  ·  Abarbanel Mental Health Center (1)  ·  Ain Shams University (1)  ·  Ajou University School of Medicine (1)  ·  Cukurova University (1)  ·  Ferrer Internacional S.A. (1)  ·  Joseph Dib (1)  ·  Peking University (1)  ·  Stony Brook University (1)  ·  Texas Tech University Health Sciences Center (1)  ·  Unity Health Toronto (1)  ·  University of Southern California (1)  ·  Yonsei University (1)

Countries

United States (6)  ·  South Korea (2)  ·  China (1)  ·  Egypt (1)  ·  Israel (1)  ·  Lebanon (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)

Top investigators

Davangere Devanand, M.D. (1)  ·  Davangere P. Devanand, MD (1)  ·  David Frey, MD (1)  ·  Gabrielle A Carlson, MD (1)  ·  George M Simpson, MD (1)  ·  Jong Yeop Kim, MD (1)  ·  Kenneth Nugent, MD (1)  ·  Laura Leso, MD (1)  ·  Michael J Pratts, MD (1)  ·  Thais B Teixeira, PharmD, PhD (1)  ·  Yonhee Shim (1)  ·  Yoram Barak, MD, MHA (1)

Results publications

PMID 21845596, PMID 23075176, PMID 24606117, PMID 27855483, PMID 29249041, PMID 30282677, PMID 32528650

NIH funding

R01AG021488 (1), R01MH055735 (1)